Real-World Evidence Generation and Evaluation of TherapeuticsNational Academies of Sciences, Engineering, and Medicine, Health and Medicine Division, Board on Health Sciences Policy, Forum on Drug Discovery, Development, and Translation, Anne B. Claiborne · First published 2017Open the Tome
Advancing the Discipline of Regulatory Science for Medical Product Development : An Update on Progress and a Forward-Looking AgendaNational Academies of Sciences, Engineering, and Medicine, Health and Medicine Division, Board on Health Sciences Policy, Forum on Drug Discovery, Development, and Translation, Anne B. Claiborne · First published 2016Open the Tome
Global Health Risk Framework : Research and Development of Medical ProductsNational Academies of Sciences, Engineering, and Medicine, Institute of Medicine, Board on Health Sciences Policy, Anne B. Claiborne, Michelle A. Mancher · First published 2016Open the Tome
Mitochondrial Replacement TechniquesAnne Claiborne, Rebecca English, Jeffrey Kahn, Committee on the Ethical and Social Policy Considerations of Novel Techniques for Prevention of Maternal Transmission of Mitochondrial DNA Diseases, Board on Health Sciences Policy · First published 2016Open the Tome
Characterizing Uncertainty in the Assessment of Benefits and Risks of Pharmaceutical ProductsDenise Caruso, Anne B. Claiborne, Forum on Drug Discovery, Development, and Translation, Board on Health Sciences Policy, Institute of Medicine · First published 2015Open the Tome
Characterizing and Communicating Uncertainty in the Assessment of Benefits and Risks of Pharmaceutical ProductsDenise Caruso, Rebecca A. English, Anne B. Claiborne, Forum on Drug Discovery, Development, and Translation, Board on Health Sciences Policy · First published 2014Open the Tome
Global Crisis of Drug-Resistant Tuberculosis and Leadership of China and the BRICS : Challenges and OpportunitiesInstitute of Medicine, Board on Health Sciences Policy, Forum on Drug Discovery, Development, and Translation, Anne B. Claiborne, Rebecca A. English · First published 2014Open the Tome
Developing and Strengthening the Global Supply Chain for Second-Line Drugs for Multidrug-Resistant TuberculosisDevelopment and Translation Staff Forum on Drug Discovery, Institute of Medicine Staff Board on Health Sciences Policy, Institute of Medicine Staff, Anne B. Claiborne, Rebecca A. English · First published 2013Open the Tome
Accelerating the Development of New Drugs and Diagnostics : Maximizing the Impact of the Cures Acceleration NetworkForum on Drug Discovery, Development, and Translation, Board on Health Sciences Policy, Institute of Medicine, Anne B. Claiborne, Steve Olson · First published 2012Open the Tome
Envisioning a Transformed Clinical Trials Enterprise in the United States : Establishing an Agenda for 2020Forum on Drug Discovery, Development, and Translation, Board on Health Sciences Policy, Institute of Medicine, Anne B. Claiborne, Rebecca A. English · First published 2012Open the Tome
Facing the Reality of Drug-Resistant Tuberculosis in IndiaForum on Drug Discovery, Development, and Translation, Board on Health Sciences Policy, Institute of Medicine, Anne B. Claiborne, Rebecca A. English · First published 2012Open the Tome
Facing the Reality of Drug-Resistant Tuberculosis in India : Challenges and Potential SolutionsInstitute of Medicine, Board on Health Sciences Policy, Forum on Drug Discovery, Development, and Translation, Anne B. Claiborne, Rita S. Guenther · First published 2012Open the Tome
Public Engagement and Clinical Trials : New Models and Disruptive TechnologiesInstitute of Medicine, Board on Health Sciences Policy, Forum on Drug Discovery, Development, and Translation, Anne B. Claiborne, Rebecca A. English · First published 2012Open the Tome
Strengthening a Workforce for Innovative Regulatory Science in Therapeutics DevelopmentInstitute of Medicine, Board on Health Sciences Policy, Forum on Drug Discovery, Development, and Translation, Anne B. Claiborne, Steve Olson · First published 2012Open the Tome
Advancing Regulatory Science for Medical Countermeasure DevelopmentInstitute of Medicine, Board on Health Sciences Policy, Forum on Medical and Public Health Preparedness for Catastrophic Events, Forum on Drug Discovery, Development, and Translation, Anne B. Claiborne · First published 2011Open the Tome
Building a National Framework for the Establishment of Regulatory Science for Drug DevelopmentYeonwoo Lebovitz, Rebecca English, Anne Claiborne, Forum on Drug Discovery, Development, and Translation, Institute of Medicine · First published 2011Open the Tome
Building a National Framework for the Establishment of Regulatory Science for Drug DevelopmentInstitute of Medicine, Board on Health Sciences Policy, Forum on Drug Discovery, Development, and Translation, Anne B. Claiborne, Rebecca A. English · First published 2011Open the Tome
Emerging Threat of Drug-Resistant Tuberculosis in Southern AfricaSteve Olson, Yeonwoo Lebovitz, Anne Claiborne, Forum on Drug Discovery, Development, and Translation, Institute of Medicine · First published 2011Open the Tome
Emerging Threat of Drug-Resistant Tuberculosis in Southern Africa : Global and Local Challenges and SolutionsAcademy of Science of South Africa, Institute of Medicine, Board on Health Sciences Policy, Forum on Drug Discovery, Development, and Translation, Anne Claiborne · First published 2011Open the Tome
New Profile of Drug-Resistant Tuberculosis in Russia : A Global and Local PerspectiveRussian Academy of Medical Sciences, Institute of Medicine, Board on Health Sciences Policy, Forum on Drug Discovery, Development, and Translation, Anne Claiborne · First published 2011Open the Tome
